TYRA•benzinga•
Piper Sandler Assumes Tyra Biosciences at Overweight, Announces Price Target of $33
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 21, 2025 by benzinga